InnoAlliance Founded in San Francisco, U.S.A.

InnoStar was listed on the STAR Market of Shanghai Stock Exchange (Stock code: 688710).

InnoStar’s headquarters and innovation transformation center construction project started in Shanghai International Medical Zone

InnoStar Shenzhen successfully passed the NMPA GLP certification for the first time

InnoStar Shenzhen successfully received the AAALAC certification for the first time

Shanghai headquarters received the AAALAC certification for the fifth time

Nantong InnoStar's expanded laboratory and office buildings were put into operation.

Shanghai headquarters passed the periodical GLP inspection by Shanghai authorities.

Shanghai headquarters received the CAP certification for the fourth time.

Shanghai headquarters successfully passed the clinical sample analysis experiment (BE) inspection.

Huangshan InnoStar Bio-tech Co., Ltd. was established.

Nantong InnoStar received the NMPA GLP certification for additional studies.

Huangshan InnoStar received the license of domestication and breeding of wild animals under national priority-protection.

Shenzhen InnoStar Biomedical Safety Evaluation and Research Institute Co., Ltd. was established.

Nantong InnoStar received the NMPA GLP certification for the first time.

Shanghai headquarters received the OECD GLP certification (Netherlands) for the fourth time.

Shanghai headquarters passed the NMPA GLP inspection for the fourth time.

Nantong InnoStar received the AAALAC certification for the first time.

Nantong InnoStar Bio-tech Co., Ltd. was constructed and put into operation.

Shanghai headquarters passed the inspection by the U.S Food and Drug Administration (FDA) for the second time.

After the shareholding system reform, Shanghai lnnoStar Bio-tech Co., LTD was formally established.

Shanghai headquarters received the AAALAC certification for the second time.

Shanghai headquarters received the OECD GLP certification (Netherlands) for the third time.

Shanghai lnnoStar received the CAP certification after re-inspection.

Shanghai headquarters received the certification from the College of American Pathologists (CAP) for the first time.

Shanghai headquarters received the NMPA GLP certification for the second time.

Shanghai headquarters received the OECD GLP certification (Netherlands) for the second time.

Pharmaceutical Metabolism Research Division was founded.

Shanghai headquarters passed the inspection by the U.S FDA for the first time.

Shanghai headquarters received the OECD GLP certification (Netherlands) for the first time.

Shanghai headquarters received the NMPA GLP certification for the first time.

Shanghai headquarters received the AAALAC certification for the first time.

Shanghai InnoStar Bio-tech Co., Ltd. was established.